Kerr on Oncology

• TMB Is Not a Universal Predictive Biomarker   A compelling new study shows why we should not rush to consider tumor mutational burden a pan-tumor predictive marker.
  Medscape Oncology, May 18, 2021
• When Medical Messages Are Lost in Translation   Dr David Kerr discusses examples of medical communication being lost in translation.
  Medscape Oncology, April 13, 2021
• Cancer News to 'Shout From the Rooftops'   Between 1988 and 2021, 5 million cancer deaths have been avoided because of improvements in prevention, early diagnosis, and treatment, according to a new study.
  Medscape Oncology, March 16, 2021
• When Your Cancer Patient Attempts Suicide   After one of Dr David Kerr's patients attempted suicide, it made him think about the degree of suicidal ideation that may occur in cancer patients and how oncologists can better help.
  Medscape Oncology, March 11, 2021
• What Drives an Exceptional Response to Cancer Treatment?   Dr David Kerr implores us to cherish the 'unusual patients,' as they may be key to better understanding those cancers that exhibit exceptional responses to treatment.
  Medscape Oncology, February 23, 2021
• COVID-19 Has Wiped Out Cancer Research Fundraising   'The impact on fundamental translational clinical research will be enormous and will echo forward for many years,' Dr Kerr laments.
  Medscape Oncology, February 17, 2021
• Did the Wise Men Notice the Babinski Sign in the Christ Child?   Dr David Kerr reflects on a timely observational analysis of the Babinski sign in the Christ Child, and wonders whether the wise men were as astute to it as the greatest Renaissance artists seemed to be.
  Medscape Oncology, December 24, 2020
• The Invisible Impact of COVID Delays on Cancer Treatment   Dr David Kerr discusses recent findings from a meta-analysis investigating the effects of cancer treatment delays during the pandemic on mortality.
  Medscape Oncology, December 07, 2020
• Remarkable 'Music of Mourning' From a Reclusive Ethiopian Nun   A grieving widow introduces David Kerr to a new composer, which moves him to muse about the music he turns to for solace.
  Medscape Oncology, December 02, 2020
• Cancer Care During COVID: It's Been a Mixed Experience   Professor David Kerr discusses his experiences delivering cancer care during the COVID-19 pandemic.
  Medscape Oncology, November 18, 2020
• Viagra to Fight Cancer? (Plus an 'Immensely Embarrassing' Story)   Dr David Kerr discusses recent data on phosphodiesterase-5 inhibitor use in patients with colorectal cancer, and his own experience with Viagra.
  Medscape Oncology, October 15, 2020
• ESMO 2020 David Kerr on ESMO's Most Important Colorectal Cancer Trials   Dr David Kerr discusses four studies that caught his eye at this year's virtual ESMO meeting.
  Medscape Oncology, October 09, 2020
• Cancer Research at a Crossroads: Adaptation Is Key   Despite the challenges of conducting cancer clinical research during a pandemic, Dr David Kerr says good things may come out of it.
  Medscape Oncology, September 14, 2020
• It's Time to Cast a Wider Net With DPD Testing   Pharmacogenomic testing may not be capturing fluoropyrimidine toxicity risk in some ethnicities. Dr David Kerr asks a philosophical question: Shouldn't we 'serve all rather than some'?
  Medscape Oncology, September 09, 2020
• Chadwick Boseman's Legacy May Be Bigger Than His Films   Dr David Kerr hopes the actor's battle with colorectal cancer will lead us to do more to understand the biology of colorectal cancer in young African Americans.
  Medscape Oncology, September 08, 2020
• Can an Oncologist Be Sentimental?   Dr David Kerr shares that he has become more sentimental as he has gotten older, and challenges us to think about whether sentimentality plays a part in our own lives and in how we practice medicine.
  Medscape Oncology, August 07, 2020
• A Pandemic Silver Lining: Cancer Research Is Going Remote   Dr David Kerr discusses the impact of COVID-19 on cancer research.
  Medscape Oncology, July 22, 2020
• Treating Colorectal Cancer in the COVID-19 Era Drs David Kerr and David Henry discuss the data behind Kerr's recent recommendations on what adjustments may be necessary during the pandemic.
  Medscape Oncology, July 21, 2020
• New Study Supports Treating Cancer Now   Dr David Kerr comments on a recent study that looked at one of the big unknowns when COVID-19 started: whether there is an increased risk for mortality for cancer patients undergoing chemotherapy.
  Medscape Oncology, July 01, 2020
• ASCO 2020: GI Cancer Highlights From David Kerr   Dr David Kerr discusses recent data on colorectal cancer, presented at the virtual ASCO meeting.
  Medscape Oncology, June 26, 2020